Nuveen Asset Management, LLC - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 70 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 2.51 and the average weighting 0.0%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$655,000
+45.2%
385,140
+6.0%
0.00%
Q4 2020$451,000
-12.3%
363,425
+0.5%
0.00%
Q3 2020$514,000
+38.2%
361,665
+17.6%
0.00%
Q2 2020$372,000
-25.2%
307,442
-27.0%
0.00%
Q1 2020$497,000
-44.1%
421,071
-0.0%
0.00%
Q4 2019$889,000
+101.1%
421,200
+109.4%
0.00%
Q3 2019$442,000
-13.2%
201,1890.0%0.00%
Q2 2019$509,000201,1890.00%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
LINCOLN CAPITAL CORP 62,000$216,0000.20%
Monashee Investment Management LLC 187,190$651,0000.15%
Cedar Wealth Management, LLC 46,395$161,0000.10%
BCWM, LLC 35,100$122,0000.06%
Tibra Equities Europe Ltd 149,595$521,0000.05%
Ahrens Investment Partners LLC 30,900$108,0000.05%
ExodusPoint Capital Management, LP 151,904$529,0000.04%
Laurion Capital Management LP 833,400$2,900,0000.04%
Alpine Global Management, LLC 33,928$118,0000.03%
Cornerstone Capital, Inc. 57,550$200,0000.03%
View complete list of ACELRX PHARMACEUTICALS INC shareholders